A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

Recruiting

Phase 1

PF-08103402A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

Sponsor:

Pfizer

Code:

NCT07660731

Conditions

Healthy Volunteer Study

Healthy Adults

Healthy Participants

Asthma

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Accepted

Interventions

PF-08103402

Placebo

Midazolam

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-04. This information was provided to ClinicalTrials.gov by Pfizer on 2026-06-29.